Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-05-01T06:57:14.951Z Has data issue: false hasContentIssue false

2 - Neurodegenerative disorders

Published online by Cambridge University Press:  15 December 2009

A. J. Larner
A. J. Larner
Affiliation:
Walton Centre for Neurology and Neurosurgery, Liverpool
Get access

Summary

Alzheimer's disease (AD)

Alzheimer's disease (AD) is the archetypal neurodegenerative cognitive disorder (Larner, 2008). Alois Alzheimer's critical contribution, which later prompted Emil Kraepelin to bestow the eponym upon the condition, was to link the clinical phenotype of cognitive decline with specific neuropathological findings, namely neurofibrillary tangles (Hodges, 2006; Larner 2006a).

Initially conceived of as a rare disease of the presenium, it was not until the 1960s that neuropsychological (Blessed et al., 1968) and neuropathological (Tomlinson et al., 1968, 1970) studies showed that most cases of ‘senile dementia’ were identical to AD. Clinical diagnostic criteria for AD have been developed by the National Institute of Neurologic and Communicative Disorders and Stroke, and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) workgroup, with definite, probable, and possible categories (McKhann et al., 1984). Clinical criteria are also available from the American Psychiatric Association's (1994) Diagnostic and Statistical Manual (DSM-IV). Generally these criteria perform well, with >80% accuracy of clinical diagnosis, hence highly sensitive for an antemortem diagnosis of AD, although specificity is poorer such that other dementias may erroneously be identified as AD. Neuropathological criteria are also available for AD, based on the quantitation and distribution of the hallmark features, senile plaques and neurofibrillary tangles (Mirra et al., 1991; Braak & Braak, 1991; National Institute on Aging, 1997).

Epidemiological studies have shown that the prevalence of AD increases steeply with increasing age, with over 50% of over-85-year-olds being affected.

Type
Chapter
Information
Neuropsychological Neurology
The Neurocognitive Impairments of Neurological Disorders
 , pp. 39 - 89
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1994.
Amieva, H, Jacqmin-Gadda, H, Orgogozo, JM, et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 2005; 128: 1093–101.CrossRefGoogle ScholarPubMed
Bäckman, L, Jones, S, Berger, AK, Laukka, EJ, Small, BJ. Multiple cognitive deficits during the transition to Alzheimer's disease. J Intern Med 2004; 256: 195–204.CrossRefGoogle ScholarPubMed
Bäckman, L, Small, BJ, Fratiglioni, L.Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001; 124: 96–102.CrossRefGoogle ScholarPubMed
Baddeley, AD, Baddeley, HA, Bucks, RS, Wilcock, GK.Attentional control in Alzheimer's disease. Brain 2001; 124: 1492–508.CrossRefGoogle ScholarPubMed
Ball, JA, Lantos, PL, Jackson, M, et al. Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry 1993; 56: 1020–3.CrossRefGoogle ScholarPubMed
Benson, DF, Davis, RJ, Snyder, BD.Posterior cortical atrophy. Arch Neurol 1988; 45: 789–93.CrossRefGoogle ScholarPubMed
Binetti, G, Magni, E, Padovani, A, et al. Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 60: 91–3.CrossRefGoogle ScholarPubMed
Blessed, G, Tomlinson, BE, Roth, M.The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797–811.CrossRefGoogle ScholarPubMed
Boeve, BF, Maraganore, MD, Parisi, JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795–800.CrossRefGoogle ScholarPubMed
Braak, H, Braak, E.Neuropathological stageing [sic] of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239–59.CrossRefGoogle ScholarPubMed
Bright P, Kopelman MD. Remote memory in Alzheimer's disease. In: Morris, RG, Becker, JT (eds.), Cognitive Neuropsychology of Alzheimer's Disease (2nd edition). Oxford: Oxford University Press, 2004: 141–51.Google Scholar
Brun A, Gustafson L. Clinical symptoms and neuropathology in organic dementing disorders affecting the frontal lobes. In: Risberg, J, Grafman, J (eds.), The Frontal Lobes: Development, Function and Pathology. Cambridge: Cambridge University Press, 2006: 199–221 [at 212–13].CrossRefGoogle Scholar
Cerhan, JH, Ivnik, RJ, Smith, GE, et al. Diagnostic utility of letter fluency, category fluency, and fluency difference scores in Alzheimer's disease. Clin Neuropsychol 2002; 16: 35–42.CrossRefGoogle ScholarPubMed
Chen, P, Ratcliff, G, Belle, SH, et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000; 55: 1847–53.CrossRefGoogle ScholarPubMed
Chen, P, Ratcliff, G, Belle, SH, et al. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001; 58: 853–8.CrossRefGoogle ScholarPubMed
Cherry, BJ, Buckwalter, JG, Henderson, VW.Better preservation of memory span relative to supraspan immediate recall in Alzheimer's disease. Neuropsychologia 2002; 40: 846–52.CrossRefGoogle ScholarPubMed
Christensen, H, Kopelman, MD, Stanhope, N, Lorentz, I, Owen, P.Rates of forgetting in Alzheimer dementia. Neuropsychologia 1998; 36: 547–57.CrossRefGoogle ScholarPubMed
Collette, F, Linden, M, Salmon, E.Executive dysfunction in Alzheimer's disease. Cortex 1999; 35: 57–72.CrossRefGoogle ScholarPubMed
Cronin-Golomb, A, Hof, PR (eds.). Vision in Alzheimer's Disease. Basel: Karger, 2004.CrossRefGoogle Scholar
Croot, K, Hodges, JR, Xuereb, JH, Patterson, K.Phonological and articulatory impairment in Alzheimer's disease: a single case series. Brain Lang 2001; 75: 277–309.CrossRefGoogle Scholar
Cruts, M, Duijn, CM, Backhovens, H, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998; 7: 43–51.CrossRefGoogle Scholar
Crystal, HA, Horoupian, DS, Katzman, R, Jotkowicz, S.Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome. Ann Neurol 1982; 12: 186–8.CrossRefGoogle ScholarPubMed
Cummings, JL, Benson, DF, Hill, MA, Read, S.Aphasia in dementia of the Alzheimer type. Neurology 1985; 35: 394–7.CrossRefGoogle ScholarPubMed
Delacourte, A, David, JP, Sergeant, N, et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999; 52: 1158–65.CrossRefGoogle ScholarPubMed
Derouesne, C, Lagha-Pierucci, S, Thibault, S, Baudouin-Madec, V, Lacomblez, L.Apraxic disturbances in patients with mild to moderate Alzheimer's disease. Neuropsychologia 2000; 38: 1760–9.CrossRefGoogle ScholarPubMed
Doran, M, du Plessis, DG, Enevoldson, TP, et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci 2003; 216: 127–34.CrossRefGoogle ScholarPubMed
Doran, M, Larner, AJ.Prominent behavioural and psychiatric symptoms in early-onset Alzheimer's disease in a sib pair with the presenilin-1 gene R269G mutation. Eur Arch Psychiatry Clin Neurosci 2004; 254: 187–9.CrossRefGoogle Scholar
Duff Canning, SJ, Leach, L, Stuss, D, Ngo, L, Black, SE.Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology 2004; 62: 556–62.CrossRefGoogle Scholar
Edwards, DF, Deuel, RK, Baum, CM, Morris, JC.A quantitative analysis of apraxia in senile dementia of Alzheimer type: stage-related differences in prevalence and type. Dementia 1991; 2: 142–9.Google Scholar
Emery, VO.Language impairment in dementia of the Alzheimer type: a hierarchical decline?Int J Psychiatry Med 2000; 30: 145–64.CrossRefGoogle ScholarPubMed
Faber-Langendoen, K, Morris, JC, Knesevich, JW, et al. Aphasia in senile dementia of the Alzheimer type. Ann Neurol 1988; 23: 365–70.CrossRefGoogle ScholarPubMed
Fox, NC, Kennedy, AM, Harvey, RJ, et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 1997; 120: 491–501.CrossRefGoogle Scholar
Fox, NC, Warrington, EK, Freeborough, PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain 1996; 119: 2001–7.CrossRefGoogle ScholarPubMed
Fox, NC, Warrington, EK, Seiffer, AL, Agnew, SK, Rossor, MN.Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease: a longitudinal prospective study. Brain 1998; 121: 1631–9.CrossRefGoogle ScholarPubMed
Galton, CJ, Patterson, K, Xuereb, JH, Hodges, JR.Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000; 123: 484–98.CrossRefGoogle ScholarPubMed
Garrard, P, Maloney, LM, Hodges, JR, Patterson, K.The effects of very early Alzheimer's disease on the characteristics of writing by a renowned author. Brain 2005; 128: 250–60.CrossRefGoogle ScholarPubMed
Garrard P, Patterson K, Hodges JR. Semantic processing in Alzheimer's disease. In: Morris, RG, Becker, JT (eds.), Cognitive Neuropsychology of Alzheimer's Disease (2nd edition). Oxford: Oxford University Press, 2004: 179–96.Google Scholar
Godbolt, AK, Beck, JA, Collinge, J, et al. A presenilin 1 R278I mutation presenting with language impairment. Neurology 2004a; 63: 1702–4.CrossRefGoogle Scholar
Godbolt, AK, Cipolotti, L, Watt, H, et al. The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. Arch Neurol 2004b; 61: 1743–8.CrossRefGoogle Scholar
Green, RC, Goldstein, FC, Mirra, SS, et al. Slowly progressive apraxia in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995; 59: 312–15.CrossRefGoogle ScholarPubMed
Hegerl, U, Möller, HJ.Electroencephalography as a diagnostic instrument in Alzheimer's disease: reviews and perspectives. Int Psychogeriatr 1997; 9 (suppl 1): 237–46.CrossRefGoogle Scholar
Henry, JD, Crawford, JR, Phillips, LH.Verbal fluency performance in dementia of the Alzheimer type: a meta-analysis. Neuropsychologia 2004; 42: 1212–22.CrossRefGoogle ScholarPubMed
Hodges, JR.Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain 2006; 129: 2811–22.CrossRefGoogle ScholarPubMed
Hodges, JR, Davies, RR, Xuereb, JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399–406.CrossRefGoogle ScholarPubMed
Hodges, JR, Salmon, DP, Butters, N.The nature of the naming deficit in Alzheimer's and Huntington's disease. Brain 1991; 114: 1547–58.CrossRefGoogle ScholarPubMed
Hodges, JR, Salmon, DP, Butters, N.Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge?Neuropsychologia 1992; 30: 301–14.CrossRefGoogle ScholarPubMed
Huff, FJ, Corkin, S, Growden, JH.Semantic impairment and anomia in Alzheimer's disease. Brain Lang 1986; 28: 235–49.CrossRefGoogle ScholarPubMed
Johnson, JK, Head, E, Kim, R, Starr, A, Cotman, CW.Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 1999; 56: 1233–9.CrossRefGoogle ScholarPubMed
Jorm, AF.Subtypes of Alzheimer's disease: a conceptual analysis. Psychol Med 1985; 15: 543–53.CrossRefGoogle ScholarPubMed
Kertesz A. Language in Alzheimer's disease. In: Morris, RG, Becker, JT (eds.), Cognitive Neuropsychology of Alzheimer's Disease (2nd edition). Oxford: Oxford University Press, 2004: 197–218.Google Scholar
Kim, E, Lee, Y, Lee, J, Han, SH.A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy. Clin Neurol Neurosurg 2005; 108: 97–101.CrossRefGoogle ScholarPubMed
Klunk, WE, Engler, H, Nordberg, A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306–19.CrossRefGoogle ScholarPubMed
Knopman, DS, DeKosky, ST, Cummings, JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143–53.CrossRefGoogle ScholarPubMed
Kurlan, R, Richard, IH, Papka, M, Marshall, F.Movement disorders in Alzheimer's disease: more rigidity of definitions is needed. Mov Disord 2000; 15: 24–9.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Lafleche, G, Albert, MS.Executive function deficits in mild Alzheimer's disease. Neuropsychology 1995; 9: 313–20.CrossRefGoogle Scholar
Lanctôt, KL, Hermann, N, Yau, KK, et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ 2003; 169: 557–64.Google ScholarPubMed
Larner, AJ.Getting it wrong: the clinical misdiagnosis of Alzheimer's disease. Int J Clin Pract 2004; 58: 1092–4.CrossRefGoogle ScholarPubMed
Larner, AJ.‘Dementia unmasked’: atypical, acute aphasic, presentations of neurodegenerative dementing disease. Clin Neurol Neurosurg 2005; 108: 8–10.CrossRefGoogle Scholar
Larner, AJ.Alzheimer 100. Adv Clin Neurosci Rehabil 2006a; 6 (5): 24.Google Scholar
Larner, AJ.‘Frontal variant Alzheimer's disease’: a reappraisal. Clin Neurol Neurosurg 2006b; 108: 705–8.CrossRefGoogle Scholar
Larner, AJ.Frequency of agnosic, apraxic and aphasic presentations of Alzheimer's disease. Eur J Neurol 2006c; 13 (suppl 2): 193 (abstract P2098).Google Scholar
Larner, AJ.Do cholinesterase inhibitors alter the course of dementia?Prog Neurol Psych 2007; 11 (5): 26–8.CrossRefGoogle Scholar
Larner AJ. Alzheimer's disease. In: Cappa, S, Abutalebi, J, Demonet, JF, Fletcher, P, Garrard, P (eds.), Cognitive Neurology: a Clinical Textbook. Oxford: Oxford University Press, 2008: in press.CrossRefGoogle Scholar
Larner, AJ, Doran, M.Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 2006; 253: 139–58.CrossRefGoogle ScholarPubMed
Larner, AJ, du Plessis, DG.Early-onset Alzheimer's disease with presenilin-1 M139V mutation: clinical, neuropsychological and neuropathological study. Eur J Neurol 2003; 10: 319–23.CrossRefGoogle ScholarPubMed
Lawrence, AD, Sahakian, BJ.Alzheimer's disease, attention, and the cholinergic system. Alzheimer Dis Assoc Disord 1995; 9 (suppl 2): 43–9.CrossRefGoogle ScholarPubMed
Levine, DN, Lee, JM, Fisher, CM.The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 1993; 43: 305–13.CrossRefGoogle ScholarPubMed
Lopez, OL, Becker, JT, Wisniewski, S, et al. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72: 310–14.CrossRefGoogle ScholarPubMed
Lozsadi, DA, Larner, AJ.Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease. Dement Geriatr Cogn Disord 2006; 22: 121–4.CrossRefGoogle ScholarPubMed
McKhann, G, Drachman, D, Folstein, M, et al. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer's disease. Neurology 1984; 34: 939–44.CrossRefGoogle Scholar
Mackenzie, Ross SJ, Graham, N, Stuart-Green, L, et al. Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61: 388–95.Google Scholar
Mendez, MF, Ghajarania, M, Perryman, KM.Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord 2002; 14: 33–40.CrossRefGoogle ScholarPubMed
Mendez, MF, Lim, GTH.Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 2003; 20: 791–803.CrossRefGoogle ScholarPubMed
Mendez, MF, Zander, BA.Dementia presenting with aphasia: clinical characteristics. J Neurol Neurosurg Psychiatry 1991; 54: 542–5.CrossRefGoogle ScholarPubMed
Mirra, SS, Heyman, A, McKeel, D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479–86.CrossRefGoogle Scholar
Morris, RG, Becker, JT (eds.). Cognitive Neuropsychology of Alzheimer's Disease (2nd edition). Oxford: Oxford University Press, 2004.Google Scholar
National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease. Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18 (suppl 4): S1–2.
Nestor, PJ, Caine, D, Fryer, TD, Clarke, J, Hodges, JR.The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET. J Neurol Neurosurg Psychiatry 2003; 74: 1521–9.CrossRefGoogle ScholarPubMed
Newman, SK, Warrington, EK, Kennedy, AM, Rossor, MN.The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. J Neurol Neurosurg Psychiatry 1994; 57: 967–72.CrossRefGoogle Scholar
Ochipa, C, Rothi, LJG, Heilman, KM.Conceptual apraxia in Alzheimer's disease. Brain 1992; 115: 1061–71.CrossRefGoogle ScholarPubMed
Overman AA, Becker JT. Information processing defects in episodic memory in Alzheimer's disease. In: Morris, RG, Becker, JT (eds.), Cognitive Neuropsychology of Alzheimer's Disease (2nd edition). Oxford: Oxford University Press, 2004: 121–40.Google Scholar
Pantel, J, Schröder, J.Posterior cortical atrophy: a new dementia syndrome or a form of Alzheimer's disease [in German]. Fortschr Neurol Psychiatr 1996; 64: 492–508.CrossRefGoogle Scholar
Parasuraman R. Attentional functioning in Alzheimer's disease. In: Morris, RG, Becker, JT (eds.), Cognitive Neuropsychology of Alzheimer's Disease (2nd edition). Oxford: Oxford University Press, 2004: 81–102.Google Scholar
Parks, RW, Zec, RF, Wilson, RS (eds.). Neuropsychology of Alzheimer's Disease and Other Dementias. New York: Oxford University Press, 1993.Google Scholar
Perry, RJ, Hodges, JR.Attention and executive deficits in Alzheimer's disease: a critical review. Brain 1999; 122: 383–404.CrossRefGoogle ScholarPubMed
Pogacar, S, Williams, RS.Alzheimer's disease presenting as slowly progressive aphasia. R I Med J 1984; 67: 181–5.Google ScholarPubMed
Rapcsak, SZ, Croswell, SC, Rubens, A.Apraxia in Alzheimer's disease. Neurology 1989; 39: 664–8.CrossRefGoogle ScholarPubMed
Reisberg, B, Doody, R, Stöffler, A, et al., for the Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003; 348: 1333–41.CrossRefGoogle ScholarPubMed
Reisberg, B, Doody, R, Stöffler, A, et al. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol 2006; 63: 49–54.CrossRefGoogle ScholarPubMed
Rippon, GA, Crook, R, Baker, M, et al. Presenilin 1 mutation in an African American family presenting with atypical Alzheimer dementia. Arch Neurol 2003; 60: 884–8.CrossRefGoogle Scholar
Ritchie, CW, Ames, D, Clayton, T, Lai, R.Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine and rivastigmine for the treatment of Alzheimer disease. Am J Geriatr Psychiatry 2004; 12: 358–69.CrossRefGoogle ScholarPubMed
Royall, DR.Executive cognitive impairment: a novel perspective on dementia. Neuroepidemiol 2000; 19: 293–9.CrossRefGoogle ScholarPubMed
Salmon DP, Fennema-Notestine C. Implicit memory in Alzheimer's disease: priming and skill learning. In: Morris, RG, Becker, JT (eds.), Cognitive Neuropsychology of Alzheimer's Disease (2nd edition). Oxford: Oxford University Press, 2004: 153–78.Google Scholar
Scarmeas, N.Hadjigeorgiou, GM, Papadimitriou, A, et al. Motor signs during the course of Alzheimer disease. Neurology 2004; 63: 975–82.CrossRefGoogle ScholarPubMed
Stam CJ. Modern applications of electroencephalography in dementia diagnosis. In: Gauthier, S, Scheltens, P, Cummings, JL (eds.), Alzheimer's Disease and Related Disorders Annual 5. London: Taylor & Francis, 2006: 191–206.Google Scholar
Swanberg, MM, Tractenberg, RE, Mohs, R, Thal, LJ, Cummings, JL.Executive dysfunction in Alzheimer disease. Arch Neurol 2004; 61: 556–60.CrossRefGoogle ScholarPubMed
Tomlinson, BE, Blessed, G, Roth, M.Observations on the brains of non-demented old people. J Neurol Sci 1968; 7: 331–56.CrossRefGoogle ScholarPubMed
Tomlinson, BE, Blessed, G, Roth, M.Observations on the brains of demented old people. J Neurol Sci 1970; 11: 205–42.CrossRefGoogle ScholarPubMed
Tsolaki, M, Kokarida, K, Iakovidou, V, et al. Extrapyramidal symptoms and signs in Alzheimer's disease: prevalence and correlation with the first symptom. Am J Alzheimers Dis Other Demen 2001; 16: 268–78.CrossRefGoogle ScholarPubMed
Ungerlieder LG, Mishkin M. Two cortical visual systems. In: Ingle, DJ, Goodale, MA, Mansfield, RJW (eds.), Analysis of Visual Behavior. Cambridge, MA: MIT Press, 1982: 549–86.Google Scholar
Waldemar, G, Dubois, B, Emre, M, et al. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia: the role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol 2000; 7: 133–44.CrossRefGoogle ScholarPubMed
Waldemar G, Dubois B, Emre M, et al. Alzheimer's disease and other disorders associated with dementia. In: Hughes, R, Brainin, M, Gilhus, NE (eds.), European Handbook of Neurological Management. Oxford: Blackwell, 2006: 266–98 [also Eur J Neurol 2007; 14: e1–26].CrossRefGoogle Scholar
Warrington, EK, Agnew, SK, Kennedy, AM, Rossor, MN.Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes. J Neurol 2001; 248: 45–50.CrossRefGoogle ScholarPubMed
Whitehead, A, Perdomo, C, Pratt, RD, et al. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry 2004; 19: 624–33.CrossRefGoogle ScholarPubMed
Bathgate, D, Snowden, JS, Varma, A, Blackshaw, A, Neary, D.Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001; 103: 367–78.CrossRefGoogle ScholarPubMed
Bozeat, S, Gregory, CA, Lambon Ralph, MA, Hodges, JR.Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?J Neurol Neurosurg Psychiatry 2000; 69: 178–86.CrossRefGoogle ScholarPubMed
Brown, J, Ashworth, A, Gydesen, S, et al. Familial non-specific dementia maps to chromosome 3. Hum Mol Genet 1995; 4: 1625–8.CrossRefGoogle ScholarPubMed
Brun, A, Englund, B, Gustafson, L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57: 416–18.Google Scholar
Cairns NJ. Neuropathology of frontotemporal lobar degenerations. In: Strong, MJ (ed.), Dementia and Motor Neuron Disease. Abingdon: Informa Healthcare, 2006: 147–66.CrossRefGoogle Scholar
Chan, D, Walters, RJ, Sampson, EL, et al. EEG abnormalities in frontotemporal lobar degeneration. Neurology 2004; 62: 1628–30.CrossRefGoogle ScholarPubMed
European Concerted Action on Pick's (ECAPD) Consortium. Provisional clinical and neuroradiological criteria for the diagnosis of Pick's disease. Eur J Neurol 1998; 5: 519–20.CrossRef
Graham A, Hodges J. Pick's disease: its relationship to progressive aphasia, semantic dementia and frontotemporal dementia. In: Burns, A, O'Brien, J, Ames, D (eds.), Dementia (3rd edition). London: Hodder Arnold, 2005: 678–88.CrossRefGoogle Scholar
Gregory, CA, Hodges, JR.Dementia of frontal type and the focal lobar atrophies. Int Rev Psychiatry 1993; 5: 397–406.CrossRefGoogle Scholar
Hodges, JR, Davies, RR, Xuereb, JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399–406.CrossRefGoogle ScholarPubMed
Hodges, JR, Patterson, K, Ward, R, et al. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology 1999; 13: 31–40.CrossRefGoogle ScholarPubMed
Kertesz, A, Munoz, DG (eds.). Pick's Disease and Pick Complex. New York: Wiley-Liss, 1998.Google ScholarPubMed
Knopman, DS, Mastri, AR, Frey, WH, Sung, JH, Rustan, T.Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990; 40: 251–6.CrossRefGoogle ScholarPubMed
McKhann, GM, Albert, MS, Grossman, M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick's disease. Arch Neurol 2001; 58: 1803–9.CrossRefGoogle ScholarPubMed
Mathuranath, PS, Nestor, PJ, Berrios, GE, Rakowicz, W, Hodges, JR.A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000; 55: 1613–20.CrossRefGoogle ScholarPubMed
Miller, BL, Ikonte, C, Ponton, M, et al. A study of the Lund–Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 1997; 48: 937–42.CrossRefGoogle ScholarPubMed
Munch, C, Rosenbohm, A, Sperfeld, AD, et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 2005; 58: 777–80.CrossRefGoogle Scholar
Neary, D, Snowden, JS, Gustafson, L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546–54.CrossRefGoogle ScholarPubMed
Perry, RJ, Hodges, JR.Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 2000; 54: 2277–84.CrossRefGoogle ScholarPubMed
Ratnavalli, E, Brayne, C, Dawson, K, Hodges, JR.The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615–21.CrossRefGoogle ScholarPubMed
Rosso, SM, Donker, KL, Baks, T, et al. Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003; 126: 2016–22.CrossRefGoogle ScholarPubMed
Skibinski, G, Parkinson, NJ, Brown, J, et al. Mutations in the endosomal ESCRTIII complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37: 806–8.CrossRefGoogle ScholarPubMed
Snowden, JS, Neary, D, Mann, DMA.Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia. New York: Churchill Livingstone, 1996.Google Scholar
Varma, AR, Snowden, JS, Lloyd, JJ, et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 1999; 66: 184–8.CrossRefGoogle ScholarPubMed
Caine, D, Patterson, K, Hodges, JR, Heard, R, Halliday, G.Severe anterograde amnesia with extensive hippocampal degeneration in a case of rapidly progressive frontotemporal dementia. Neurocase 2001; 7: 57–64.CrossRefGoogle Scholar
Deakin, JB, Rahman, S, Nestor, PJ, Hodges, JR, Sahakian, BJ.Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacol 2004; 172: 400–8.Google Scholar
Doran, M, du Plessis, DG, Enevoldson, TP, et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci 2003; 216: 127–34.CrossRefGoogle ScholarPubMed
Graham, A, Davies, R, Xuereb, J, et al. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 2005; 128: 597–605.CrossRefGoogle ScholarPubMed
Gregory, CA, Serra, Mestres J, Hodges, JR.Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests?Neuropsychiatry Neuropsychol Behav Neurol 1999; 12: 128–35.Google ScholarPubMed
Hodges, JR, Davies, RR, Xuereb, JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399–406.CrossRefGoogle ScholarPubMed
Larner, AJ.‘Dementia unmasked’: atypical, acute aphasic, presentations of neurodegenerative dementing disease. Clin Neurol Neurosurg 2005; 108: 8–10.CrossRefGoogle Scholar
Lo Coco, D, Nacci, P.Frontotemporal dementia presenting with pathological gambling. J Neuropsychiatry Clin Neurosci 2004; 16: 117–18.CrossRefGoogle ScholarPubMed
Miller, BL, Cummings, J, Mishkin, F, et al. Emergence of artistic talent in frontotemporal dementia. Neurology 1998; 51: 978–82.CrossRefGoogle ScholarPubMed
Neary, D, Snowden, JS, Gustafson, L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546–54.CrossRefGoogle ScholarPubMed
Perry, RJ, Hodges, JR.Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 2000; 54: 2277–84.CrossRefGoogle ScholarPubMed
Rahman, S, Sahakian, BJ, Hodges, JR, Rogers, RD, Robbins, TW.Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain 1999; 122: 1469–93.CrossRefGoogle ScholarPubMed
Rossor, M, Warrington, EK, Cipolotti, L.The isolation of calculation skills. J Neurol 1995; 242: 78–81.CrossRefGoogle ScholarPubMed
Snowden, JS, Neary, D, Mann, DMA.Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia. New York: Churchill Livingstone, 1996: 9–58.Google Scholar
Chan, D, Fox, NC, Scahill, RI, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 2001: 49: 433–42.CrossRefGoogle ScholarPubMed
Davies, RR, Hodges, JR, Kril, JJ, et al. The pathological basis of semantic dementia. Brain 2005; 128: 1984–95.CrossRefGoogle ScholarPubMed
Evans, JJ, Heggs, AJ, Antoun, N, Hodges, JR.Progressive prosopagnosia associated with selective right temporal lobe atrophy: a new syndrome?Brain 1995; 118: 1–13.CrossRefGoogle ScholarPubMed
Garrard, P, Hodges, JR.Semantic dementia: clinical, radiological and pathological perspectives. J Neurol 2000; 247: 409–22.CrossRefGoogle ScholarPubMed
Godbolt, AK, Josephs, KA, Revesz, T, et al. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Arch Neurol 2005; 62: 1097–101.CrossRefGoogle ScholarPubMed
Graham, KS, Hodges, JR.Differentiating the roles of the hippocampal complex and the neocortex in long-term memory storage: evidence from the study of semantic dementia and Alzheimer's disease. Neuropsychology 1997; 11: 77–89.CrossRefGoogle Scholar
Hodges, JR, Patterson, K, Oxbury, S, Funnell, E.Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 1992; 115: 1783–806.CrossRefGoogle ScholarPubMed
Larner, AJ.Gambling. Adv Clin Neurosci Rehabil 2007; 7 (1): 26.Google Scholar
Larner, AJ, Brookfield, K, Flynn, A, et al. The cerebral metabolic topography of semantic dementia. J Neurol 2005; 252 (suppl 2): II106 (abstract P399).Google Scholar
Perry, RJ, Hodges, JR.Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 2000; 54: 2277–84.CrossRefGoogle ScholarPubMed
Poeck, K, Luzzatti, C.Slowly progressive aphasia in three patients: the problem of accompanying neuropsychological deficit. Brain 1988; 111: 151–68.CrossRefGoogle ScholarPubMed
Snowden, JS, Neary, D, Mann, DMA.Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia. New York: Churchill Livingstone, 1996: 91–114.Google Scholar
Thompson, SA, Patterson, K, Hodges, JR.Left/right asymmetry of atrophy in semantic dementia: behavioural–cognitive implications. Neurology 2003; 61: 1196–203.CrossRefGoogle Scholar
Warrington, EK.The selective impairment of semantic memory. Q J Exp Psychol 1975; 27: 635–57.CrossRefGoogle ScholarPubMed
Amici, S, Gorno-Tempini, ML, Ogar, JM, Dronkers, NF, Miller, BL.An overview on primary progressive aphasia and its variants. Behav Neurol 2006; 17: 77–87.CrossRefGoogle ScholarPubMed
Boeve, BF, Dickson, D, Duffy, J, et al. Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 2003; 49: 72–8.CrossRefGoogle ScholarPubMed
Doran, M, Larner, AJ.Monozygotic twins discordant for primary progressive aphasia. Alzheimer Dis Assoc Disord 2004; 18: 48–9.CrossRefGoogle ScholarPubMed
Duffy, JR, Petersen, RC.Primary progressive aphasia. Aphasiology 1992; 6: 1–15.CrossRefGoogle Scholar
Ferrer, I, Hernandez, I, Boada, M, et al. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Acta Neuropathol (Berl) 2003; 106: 419–35.CrossRefGoogle ScholarPubMed
Hodges, JR, Davies, RR, Xuereb, JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399–406.CrossRefGoogle ScholarPubMed
Kertesz A. Primary progressive aphasia. In: Kertesz, A, Munoz, DG (eds.), Pick's Disease and Pick Complex. New York: Wiley-Liss, 1998: 69–81.Google ScholarPubMed
Krefft, TA, Graff-Radford, NR, Dickson, DW, Baker, M, Castellani, RJ.Familial primary progressive aphasia. Alzheimer Dis Assoc Disord 2003; 17: 106–12.CrossRefGoogle ScholarPubMed
Rhun, E, Richard, F, Pasquier, F.Natural history of primary progressive aphasia. Neurology 2005; 65: 887–91.CrossRefGoogle ScholarPubMed
Mesulam, MM.Slowly progressive aphasia without generalized dementia. Ann Neurol 1982; 11: 592–8.CrossRefGoogle ScholarPubMed
Mesulam, MM.Primary progressive aphasia. Ann Neurol 2001; 49: 425–32.CrossRefGoogle ScholarPubMed
Mesulam MM, Weintraub S. Spectrum of primary progressive aphasia. In: Rossor, MN (ed.), Unusual Dementias. London: Bailliere Tindall, 1992: 583–609.Google ScholarPubMed
Mimura, M, Oda, T, Tsuchiya, K, et al. Corticobasal degeneration presenting with nonfluent primary progressive aphasia: a clinicopathological study. J Neurol Sci 2001; 183: 19–26.CrossRefGoogle ScholarPubMed
Mochizuki, A, Ueda, Y, Komatsuzaki, Y, et al. Progressive supranuclear palsy presenting with primary progressive aphasia: clinicopathological report of an autopsy case. Acta Neuropathol (Berl) 2003; 105: 610–14.Google ScholarPubMed
Sakurai, Y, Hashida, H, Uesugi, H, et al. A clinical profile of corticobasal degeneration presenting as primary progressive aphasia. Eur Neurol 1996; 36: 134–7.CrossRefGoogle ScholarPubMed
Snowden, JS, Neary, D, Mann, DMA.Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia. New York: Churchill Livingstone, 1996: 73–90.Google Scholar
Westbury, C, Bub, D.Primary progressive aphasia: a review of 112 cases. Brain Lang 1997; 60: 381–406.CrossRefGoogle ScholarPubMed
Baker, M, Mackenzie, IR, Pickering-Brown, SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916–19.CrossRefGoogle ScholarPubMed
Bird, TD, Nochlin, D, Poorkaj, P, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999; 122: 741–56.CrossRefGoogle Scholar
Bugiani, O, Murrell, JR, Giaccone, G, et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999; 58: 667–77.CrossRefGoogle Scholar
Cruts, M, Gijselinck, I, Zee, J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920–4.CrossRefGoogle ScholarPubMed
Delisle, MB, Murrell, JR, Richardson, R, et al. A mutation at codon 279 (N279K) in exon 10 of the tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol (Berl) 1999; 98: 62–77.CrossRefGoogle ScholarPubMed
Doran, M, du Plessis, DG, Ghadiali, EJ, et al. Familial early-onset dementia with tau intron 10 +16 mutation with clinical features similar to those of Alzheimer disease. Arch Neurol 2007; 64: 1535–9.CrossRefGoogle ScholarPubMed
Forman MS, Trojanowski JQ, Lee VMY. Hereditary tauopathies and idiopathic frontotemporal dementias. In: Esiri, MM, Trojanowski, JQ, Lee, VMY (eds.), The Neuropathology of Dementia (2nd edition). Cambridge: Cambridge University Press, 2004: 257–88.CrossRefGoogle Scholar
Foster, NL, Wilhelmsen, K, Sima, AAF, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997; 41: 706–15.CrossRefGoogle ScholarPubMed
Geschwind, DH, Robidoux, J, Alarcón, M, et al. Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol 2001; 50: 741–6.CrossRefGoogle ScholarPubMed
Hutton, M, Lendon, CL, Rizzu, P, et al. Association of missense and 5′ splice site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702–5.CrossRefGoogle ScholarPubMed
Janssen, JC, Warrington, EK, Morris, HR, et al. Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation. Neurology 2002; 58: 1161–8.CrossRefGoogle ScholarPubMed
Lanska, DJ, Currier, RD, Cohen, M, et al. Familial progressive subcortical gliosis. Neurology 1994; 44: 1633–43.CrossRefGoogle ScholarPubMed
Lendon, CL, Lynch, T, Norton, J, et al. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21–22. Neurology 1998; 50: 1546–55.CrossRefGoogle ScholarPubMed
Lynch, T, Sano, M, Marder, KS, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition–dementia–parkinsonism–amyotrophy complex. Neurology 1994; 44: 1878–84.CrossRefGoogle ScholarPubMed
Mann DMA. The genetics and molecular pathology of frontotemporal lobar degeneration. In: Burns, A, O'Brien, J, Ames, D (eds.), Dementia (3rd edition). London: Hodder Arnold, 2005: 689–701.CrossRefGoogle Scholar
Mirra, SS, Murrell, JR, Gearing, M, et al. Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol 1999; 58: 335–45.CrossRefGoogle Scholar
Morris, HR, Osaki, Y, Holton, J, et al. Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. Neurology 2003; 61: 102–4.CrossRefGoogle ScholarPubMed
Nasreddine, ZS, Loginov, M, Clark, LN, et al. From genotype to phenotype: a clinical, pathological and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 1999; 45: 704–15.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Nicholl, DJ, Greenstone, MA, Clarke, CE, et al. An English kindred with a novel recessive tauopathy and respiratory failure. Ann Neurol 2003; 54: 682–6.CrossRefGoogle ScholarPubMed
Pastor, P, Pastor, E, Carnero, C, et al. Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene. Ann Neurol 2001; 49: 263–7.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Pickering-Brown, SM, Richardson, AMT, Snowden, JS, et al. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 2002; 125: 732–51.CrossRefGoogle ScholarPubMed
Poorkaj, P, Bird, T, Wijsman, E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43: 815–25.CrossRefGoogle ScholarPubMed
Ros, R, Thobois, S, Streichenberger, N, et al. A new mutation of the τ gene, G303V, in early-onset familial progressive supranuclear palsy. Arch Neurol 2005; 62: 1444–50.CrossRefGoogle ScholarPubMed
Saito, Y, Geyer, A, Sasaki, R, et al. Early-onset, rapidly progressive familial tauopathy with R406W mutation. Neurology 2002; 58: 811–13.CrossRefGoogle ScholarPubMed
Spillantini, MG, Goedert, M, Crowther, RA, et al. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997; 94: 4113–18.CrossRefGoogle ScholarPubMed
Spillantini, MG, Murrell, JR, Goedert, M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95: 7737–41.CrossRefGoogle ScholarPubMed
Swieten, JC, Stevens, M, Rosso, SM, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 1999; 46: 617–26.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Wilhelmsen, KC, Lynch, T, Pavlov, E, Higgins, M, Nygaard, TG.Localization of disinhibition–dementia–parkinsonism–amyotrophy complex to 17q21–22. Am J Hum Genet 1994; 55: 1159–65.Google ScholarPubMed
Wszolek, ZK, Pfeiffer, RF, Bhatt, MH, et al. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol 1992; 32: 312–20.CrossRefGoogle ScholarPubMed
Wszolek, ZK, Tsuboi, Y, Uitti, RJ, et al. Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation. Brain 2001; 124: 1666–70.CrossRefGoogle ScholarPubMed
Bergmann, M, Gullotta, F, Weitbrecht, WU.Progressive subkortikale Gliose. Fortschr Neurol Psychiatr 1991; 59: 328–34.CrossRefGoogle Scholar
Gambetti, P.Prion in progressive subcortical gliosis revisited. Neurology 1997; 49: 309–10.CrossRefGoogle ScholarPubMed
Goedert, M, Spillantini, MG, Crowther, RA, et al. Tau gene mutation in familial progressive subcortical gliosis. Nature Med 1999; 5: 454–7.CrossRefGoogle ScholarPubMed
Lanska, DJ, Currier, RD, Cohen, M, et al. Familial progressive subcortical gliosis. Neurology 1994; 44: 1633–43.CrossRefGoogle ScholarPubMed
Lanska, DJ, Markesbery, WR, Cochran, E, et al. Late-onset sporadic progressive subcortical gliosis. J Neurol Sci 1998; 157: 143–7.CrossRefGoogle ScholarPubMed
Larner, AJ, Smith, ETS, Doran, M.Does MRI/MRS permit ante mortem diagnosis of progressive subcortical gliosis of Neumann?J Neurol Neurosurg Psychiatry 2003; 74: 404 (abstract 29).Google Scholar
Neumann, MA, Cohn, R.Progressive subcortical gliosis, a rare form of presenile dementia. Brain 1967; 90: 405–18.CrossRefGoogle ScholarPubMed
Petersen, RB, Tabaton, M, Chen, SG, et al. Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17. Neurology 1995; 45: 1062–7.CrossRefGoogle ScholarPubMed
Revesz, T, Daniel, SE, Lees, AJ, Will, RG.A case of progressive subcortical gliosis associated with deposition of abnormal prion protein (PrP). J Neurol Neurosurg Psychiatry 1995; 58: 759–60.CrossRefGoogle Scholar
Seitelberger, F.Präsenile gliale Dystrophie. Acta Neuropathol (Berl) 1968; Suppl 4: 109–18.Google Scholar
Vermersch, P, Daems-Monpeurt, C, Parent, M, et al. Démence sous-corticale type Neumann. Apport de l'imagérie morphologique et fonctionnelle. Rev Neurol (Paris) 1994; 150: 354–8.Google Scholar
Will, RG, Lees, AJ, Gibb, W, Barnard, RO.A case of progressive subcortical gliosis presenting clinically as Steele–Richardson–Olszewski syndrome. J Neurol Neurosurg Psychiatry 1988; 51: 1224–7.CrossRefGoogle ScholarPubMed
Braak, H, Braak, E.Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 1998; 105: 801–19.CrossRefGoogle ScholarPubMed
Thal, DR, Schultz, C, Botez, G, et al. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology. Neuropath Appl Neurobiol 2005; 31: 270–9.CrossRefGoogle ScholarPubMed
Togo, T, Sahara, N, Yen, SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002; 61: 547–56.CrossRefGoogle ScholarPubMed
Tolnay, M, Clavaguera, F.Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. Neuropathology 2004; 24: 269–83.CrossRefGoogle ScholarPubMed
Bancher, C, Jellinger, KA.Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol (Berl) 1994; 88: 565–70.CrossRefGoogle ScholarPubMed
Haraguchi, T, Ishizu, H, Takehisa, Y, et al. Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity. Neuroreport 2001; 12: 3887–90.CrossRefGoogle ScholarPubMed
Ito, Y, Kato, T, Suzuki, T, et al. Neuroradiologic and clinical abnormalities in dementia of diffuse neurofibrillary tangles with calcification (Kosaka–Shibayama disease). J Neurol Sci 2003; 209: 105–9.CrossRefGoogle Scholar
Kosaka, K.Diffuse neurofibrillary tangles with calcification: a new presenile dementia. J Neurol Neurosurg Psychiatry 1994; 57: 594–6.CrossRefGoogle ScholarPubMed
Kosaka, K, Ikeda, K.Diffuse neurofibrillary tangles with calcification in a non-demented woman. J Neurol Neurosurg Psychiatry 1996; 61: 116.CrossRefGoogle Scholar
Langlois, NEI, Grieve, JHK, Best, PV.Changes of diffuse neurofibrillary tangles with calcification (DNTC) in a woman without evidence of dementia. J Neurol Neurosurg Psychiatry 1995; 59: 103.CrossRefGoogle Scholar
McKhann, GM, Albert, MS, Grossman, M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick's disease. Arch Neurol 2001; 58: 1803–9.CrossRefGoogle ScholarPubMed
Modrego, PJ, Mojonero, J, Serrano, M, Fayed, N.Fahr's syndrome presenting with pure and progressive presenile dementia. Neurol Sci 2005; 26: 367–9.CrossRefGoogle ScholarPubMed
Tanabe, Y, Ishizu, H, Ishiguro, K, et al. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation. Neuroreport 2000; 11: 2473–7.CrossRefGoogle ScholarPubMed
Ulrich, J, Spillantini, MG, Goedert, M, et al. Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration 1992; 1: 257–84.Google Scholar
Bigio, EH, Lipton, AM, White, CL III, et al. Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropath Appl Neurobiol 2003; 29: 239–53.CrossRefGoogle ScholarPubMed
Cairns, NJ, Grossman, M, Arnold, SE, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004; 63: 1376–84.CrossRefGoogle ScholarPubMed
Josephs, KA, Holton, JL, Rossor, MN, et al. Neurofilament inclusion body disease: a new proteinopathy?Brain 2003; 126: 2291–303.CrossRefGoogle ScholarPubMed
Hamada, K, Fukuzawa, T, Yanagihara, T, et al. Dementia with ALS features and diffuse Pick body-like inclusions (atypical Pick's disease?). Clin Neuropathol 1995; 14: 1–6.Google ScholarPubMed
Abrahams, S, Goldstein, LH, Al-Chalabi, A, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1997; 62: 464–72.CrossRefGoogle ScholarPubMed
Alzheimer, A.On a case of spinal progressive muscle atrophy with accessory disease of bulbar nuclei and the cortex [in German]. Arch Psychiatr 1891; 23: 459–85.CrossRefGoogle Scholar
Bak, T, Hodges, JR.Noun–verb dissociation in three patients with motor neurone disease and aphasia. Brain Lang 1997; 60: 38–41.Google Scholar
Bak, TH, Hodges, JR.Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum?J Neurol 2001; 248: 260–70.CrossRefGoogle ScholarPubMed
Caselli, RJ, Windebank, AJ, Petersen, RC, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol 1993; 33: 200–7.CrossRefGoogle ScholarPubMed
Charcot, JM, Joffroy, A.Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antérolatéraux de la moelle épinière. Arch Physiol Norm 1869; 2: 354–67.Google Scholar
David, AS, Gillham, RA.Neuropsychological study of motor neuron disease. Psychosomatics 1986; 27: 441–5.CrossRefGoogle ScholarPubMed
Davies, RR, Hodges, JR, Kril, JJ, et al. The pathological basis of semantic dementia. Brain 2005; 128: 1984–95.CrossRefGoogle ScholarPubMed
Deymeer, F, Smith, TW, Girolami, U, Drachman, DA.Thalamic dementia and motor neuron disease. Neurology 1989; 39: 58–61.CrossRefGoogle ScholarPubMed
Doran, M, Xuereb, J, Hodges, JR.Rapidly progressive aphasia with bulbar motor neurone disease: a clinical and neuropsychological study. Behav Neurol 1995; 9: 169–80.Google Scholar
Evdokimidis, I, Constantinidis, TS, Gourtzelidis, P, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. J Neurol Sci 2002; 195: 25–33.CrossRefGoogle ScholarPubMed
Gallassi, R, Montagna, P, Morreale, A, et al. Neuropsychological, electroencephalogram and brain computed tomography findings in motor neuron disease. Eur Neurol 1989; 29: 115–20.CrossRefGoogle ScholarPubMed
Godbolt, AK, Josephs, KA, Revesz, T, et al. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Arch Neurol 2005; 62: 1097–101.CrossRefGoogle ScholarPubMed
Grimes, DA, Bergeron, CB, Lang, AE.Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999; 14: 674–80.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Hamilton, RL, Bowser, R.Alzheimer disease pathology in amyotrophic lateral sclerosis. Acta Neuropathol 2004; 107: 515–22.Google ScholarPubMed
Hosler, BA, Siddique, T, Sapp, PC, et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21–q22. JAMA 2000; 284: 1664–9.CrossRefGoogle ScholarPubMed
Hudson, AJ.Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217–47.CrossRefGoogle ScholarPubMed
Iwasaki, K, Kinoshita, M, Ikeda, K, et al. Cognitive impairment in amyotrophic lateral sclerosis and its relation to motor disabilities. Acta Neurol Scand 1990; 81: 141–3.CrossRefGoogle ScholarPubMed
Jackson, M, Lennox, G, Lowe, J.Motor neurone disease-inclusion dementia. Neurodegeneration 1995; 5: 339–50.CrossRefGoogle Scholar
Kew, JJM, Goldstein, LH, Leigh, PN, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: a neuropsychological and positron emission tomography study. Brain 1993; 116: 1399–423.CrossRefGoogle ScholarPubMed
Kirshner, HS, Tanridag, O, Thurman, L, Whetsell, WO.Progressive aphasia without dementia: two cases with focal spongiform degeneration. Ann Neurol 1987; 22: 527–32.CrossRefGoogle ScholarPubMed
Lipton, AM, White, CL, Bigio, EH.Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 2004; 108: 379–85.CrossRefGoogle ScholarPubMed
Lomen-Hoerth, C, Anderson, T, Miller, B.The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002; 59: 1077–9.CrossRefGoogle ScholarPubMed
Lomen-Hoerth, C, Murphy, J, Langmore, S, et al. Are amyotrophic lateral sclerosis patients cognitively normal?Neurology 2003; 60: 1094–7.CrossRefGoogle ScholarPubMed
Ludolph, AC, Langen, KJ, Regard, M, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 1992; 85: 81–9.CrossRefGoogle ScholarPubMed
McKhann, GM, Albert, MS, Grossman, M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick's disease. Arch Neurol 2001; 58: 1803–9.CrossRefGoogle ScholarPubMed
Mackenzie, IRA, Feldman, HH.Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J Neuropathol Exp Neurol 2005; 64: 730–9.CrossRefGoogle ScholarPubMed
Massman, PJ, Sims, J, Cooke, N, et al. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996; 61: 450–5.CrossRefGoogle ScholarPubMed
Mitsuyama, Y.Presenile dementia with motor neuron disease in Japan: a clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry 1984; 47: 953–9.CrossRefGoogle ScholarPubMed
Morris, HR, Bronstein, AM, Shaw, CE, Lees, AJ, Love, S.Clinical grand round: a rapidly progressive pyramidal and extrapyramidal syndrome with a supranuclear gaze palsy. Mov Disord 2005; 20: 826–31.CrossRefGoogle ScholarPubMed
Munch, C, Rosenbohm, A, Sperfeld, AD, et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 2005; 58: 777–80.CrossRefGoogle Scholar
Neary, D, Snowden, JS, Mann, DMA, et al. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 1990; 53: 23–32.CrossRefGoogle ScholarPubMed
Ostojic, J, Axelman, K, Lannfelt, L, Froelich-Fabre, S.No evidence of linkage to chromosome 9q21–22 in a Swedish family with frontotemporal dementia and amyotrophic lateral sclerosis. Neurosci Lett 2003; 340: 245–7.CrossRefGoogle Scholar
Rakowicz, WP, Hodges, JR.Dementia and aphasia in motor neuron disease: an underrecognised association?J Neurol Neurosurg Psychiatry 1998; 65: 881–9.CrossRefGoogle ScholarPubMed
Ringholz, GM, Appel, SH, Bradshaw, M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005; 65: 586–90.CrossRefGoogle ScholarPubMed
Sathasivam, S, Doran, M, Hancock, P, Larner, AJ.Frontotemporal lobar degeneration with motor neuron disease (FTLD/MND): experience at a cognitive function clinic. J Neurol Neurosurg Psychiatry 2007; 78: 211 (abstract 027).Google Scholar
Sathasivam, S, Shaw, PJ.Apoptosis in amyotrophic lateral sclerosis: what is the evidence?Lancet Neurol 2005; 4: 500–9.CrossRefGoogle ScholarPubMed
Schreiber, H, Gaigalat, T, Wiedemuth-Catrinescu, U, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis: a longitudinal study in 52 patients. J Neurol 2005; 252: 772–81.CrossRefGoogle ScholarPubMed
Snowden, JS, Neary, D, Mann, DMA.Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia. New York: Churchill Livingstone, 1996: 59–72.Google Scholar
Strong, MJ (ed.). Dementia and Motor Neuron Disease. Abingdon: Informa Healthcare, 2006.CrossRefGoogle Scholar
Strong, MJ, Grace, GM, Orange, JB, et al. A prospective study of cognitive impairment in ALS. Neurology 1999; 53: 1665–70.CrossRefGoogle ScholarPubMed
Talbot, PR, Goulding, PJ, Lloyd, JJ, et al. Interrelation between ‘classic’ motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 1995; 58: 541–7.CrossRefGoogle Scholar
Vercelletto, M, Ronin, M, Huvet, M, Magne, C, Feve, JR.Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and SPECT study of five clinical cases. Eur J Neurol 1999; 6: 295–9.CrossRefGoogle ScholarPubMed
Yoshida, M.Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology 2004; 24: 87–102.CrossRefGoogle ScholarPubMed
Caselli, RJ, Smith, BE, Osborne, D.Primary lateral sclerosis: a neuropsychological study. Neurology 1995; 45: 2005–9.CrossRefGoogle ScholarPubMed
Grace GM, Orange JB, Murphy MJ, et al. Primary lateral sclerosis: cognitive, language, and cerebral hemodynamic findings. In: Strong, MJ (ed.), Dementia and Motor Neuron Disease. Abingdon: Informa Healthcare, 2006: 87–97.CrossRefGoogle Scholar
Forestier, N, Maisonobe, T, Piquard, A, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 2001; 124: 1989–99.CrossRefGoogle Scholar
Piquard, A, Forestier, N, Baudoin-Madec, V, et al. Neuropsychological changes in patients with primary lateral sclerosis. Amyotroph Lateral Scler 2006; 7: 150–60.CrossRefGoogle ScholarPubMed
Pringle, CE, Hudson, AJ, Munoz, DG, et al. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992; 115: 495–520.CrossRefGoogle ScholarPubMed
Doran, M, Enevoldson, TP, Ghadiali, EJ, Larner, AJ.Mills syndrome with dementia: broadening the phenotype of FTD/MND. J Neurol 2005; 252: 846–7.CrossRefGoogle ScholarPubMed
Gastaut, JL, Bartolomei, F.Mills' syndrome: ascending (or descending) progressive hemiplegia. A hemiplegic form of primary lateral sclerosis?J Neurol Neurosurg Psychiatry 1994; 57: 1280–1.CrossRefGoogle ScholarPubMed
Malin, JP, Poburski, R, Reusche, E.Clinical variants of amyotrophic lateral sclerosis: hemiplegic type of ALS and Mills syndrome. A critical review [in German]. Fortschr Neurol Psychiatr 1986; 54: 101–5.CrossRefGoogle Scholar
Mills, CK.A case of unilateral progressive ascending paralysis probably presenting a new form of degenerative disease. J Nerv Ment Dis 1900; 27: 195–200.CrossRefGoogle Scholar
Pringle, CE, Hudson, AJ, Munoz, DG, et al. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992; 115: 495–520.CrossRefGoogle ScholarPubMed
Ala, T, Beh, GO, Frey, WM. Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease. Neurology 2000; 54: 843–8.CrossRefGoogle ScholarPubMed
Blass, DM, Hatanpaa, KJ, Brandt, J, et al. Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology 2004; 63: 492–7.CrossRefGoogle ScholarPubMed
Corey-Bloom, J, Sabbagh, MN, Bondi, MW, et al. Hippocampal sclerosis contributes to dementia in the elderly. Neurology 1997; 48: 154–60.CrossRefGoogle ScholarPubMed
Hatanpaa, KJ, Blass, DM, Pletnikova, O, et al. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 2004; 63: 538–42.CrossRefGoogle ScholarPubMed
Leverenz, JB, Agustin, CM, Tsuang, D, et al. Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 2002; 59: 1099–106.CrossRefGoogle ScholarPubMed
McKeel, DW, Burns, JM, Meuser, TM, Morris, JC.An Atlas of Investigation and Diagnosis: Dementia. Oxford: Clinical Publishing, 2007: 172.Google Scholar
McKhann, GM, Albert, MS, Grossman, M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick's disease. Arch Neurol 2001; 58: 1803–9.CrossRefGoogle ScholarPubMed
Hu, MTM, Ellis, CM, Al-Chalabi, A, Leigh, PN, Shaw, CE.Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1998; 65: 950–1.CrossRefGoogle ScholarPubMed
Wicks, P, Abrahams, S, Leigh, PN, Williams, T, Goldstein, LH.Absence of cognitive, behavioural, or emotional dysfunction in progressive muscular atrophy. Neurology 2006; 67: 1718–19.CrossRefGoogle ScholarPubMed
Aarsland D. Dementia in Parkinson's disease. In: O'Brien, J, McKeith, I, Ames, D, Chiu, E (eds.), Dementia with Lewy Bodies and Parkinson's Disease Dementia. London: Taylor & Francis, 2006: 221–39.Google Scholar
Aarsland, D, Laake, K, Larsen, JP, et al. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2002; 72: 708–12.CrossRefGoogle ScholarPubMed
Ala, T, Hughes, LF, Kyrouac, GA, Ghobrial, MW, Elble, RJ.The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2002; 17: 503–9.CrossRefGoogle ScholarPubMed
Ballard, CG, Ayre, G, O'Brien, J, et al. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1999; 10: 104–8.CrossRefGoogle ScholarPubMed
Braak, H, Del Tredici, K, Rüb, U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197–211.CrossRefGoogle ScholarPubMed
Braak, H, Rüb, U, Jansen-Steur, ENH, Del Tredici, K, Vos, RAI.Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64: 1404–10.CrossRefGoogle ScholarPubMed
Brown, P, Marsden, CD.What do the basal ganglia do?Lancet 1998; 351: 1801–4.CrossRefGoogle Scholar
Brown, RG, Marsden, CD.How common is dementia in Parkinson's disease?Lancet 1984; 2: 1262–5.CrossRefGoogle ScholarPubMed
Brown, RG, Marsden, CD.Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain 1991; 114: 215–31.Google ScholarPubMed
Burkhardt, CR, Filley, CM, Kleinschmidt-DeMasters, BK, et al. Diffuse Lewy body disease and progressive dementia. Neurology 1988; 38: 1520–8.CrossRefGoogle ScholarPubMed
Byrne, EJ, Lennox, G, Lowe, J, Godwin-Austen, RB.Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52: 709–17.CrossRefGoogle ScholarPubMed
Calderon, J, Perry, R, Erzinclioglu, S, et al. Perception, attention and working memory are disproportionately impaired in dementia with Lewy body (LBD) compared to Alzheimer's disease (AD). J Neurol Neurosurg Psychiatry 2001; 70: 157–64.CrossRefGoogle Scholar
Canavan, AGM, Passingham, RE, Marsden, CD.Prism adaptation and other tasks involving spatial abilities in patients with Parkinson's disease, patients with frontal lobe lesions and patients with unilateral temporal lobectomies. Neuropsychologia 1990; 28: 969–84.CrossRefGoogle ScholarPubMed
Charcot, JM.Leçons sur les maladies du système nerveux. Paris: Delahaye, 1985 [1875]: 179.Google Scholar
Cormack, F, Aarsland, D, Ballard, C, Tovée, MJ.Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry 2004a; 19: 371–7.CrossRefGoogle Scholar
Cormack, F, Gray, A, Ballard, C, Tovée, MJ.A failure of ‘pop-out’ in visual search tasks in dementia with Lewy bodies as compared to Alzheimer's and Parkinson's disease. Int J Geriatr Psychiatry 2004b; 19: 763–72.CrossRefGoogle Scholar
Cummings, JL, Darkins, A, Mendez, M, Hill, MA, Benson, DF.Alzheimer's disease and Parkinson's disease: comparison of speech and language alterations. Neurology 1988; 38: 680–4.CrossRefGoogle ScholarPubMed
Dodd, ML, Klos, KJ, Bower, JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005; 62: 1377–81.CrossRefGoogle ScholarPubMed
Doran, M, Larner, AJ.EEG findings in dementia with Lewy bodies causing diagnostic confusion with sporadic Creutzfeldt–Jakob disease. Eur J Neurol 2004; 11: 838–41.CrossRefGoogle ScholarPubMed
Doubleday, EK, Snowden, JS, Varma, A, Neary, D.Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72: 602–7.CrossRefGoogle ScholarPubMed
Downes, JJ, Priestley, NM, Doran, M, et al. Intellectual, mnemonic and frontal functions in dementia with Lewy bodies: a comparison with early and advanced Parkinson's disease. Behav Neurol 1998; 11: 173–83.CrossRefGoogle ScholarPubMed
Dujardin, K, Degreef, JF, Rogelet, P, Defebvre, L, Destee, A.Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. J Neurol 1999a; 246: 783–8.CrossRefGoogle Scholar
Dujardin, K, Duhamel, A, Becquet, E, et al. Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1999b; 67: 323–8.CrossRefGoogle Scholar
du Plessis, DG, Larner, AJ.Phenotypic similarities causing clinical misdiagnosis of pathologically confirmed sporadic Creutzfeldt–Jakob disease as dementia with Lewy bodies. Clin Neurol Neurosurg 2008; 110: 194–7.CrossRefGoogle ScholarPubMed
Emre, M.Dementia associated with Parkinson's disease. Lancet Neurol 2003; 2: 229–37.CrossRefGoogle ScholarPubMed
Emre M. Cholinesterase inhibitors in the treatment of dementia associated with Parkinson's disease. In: Gauthier, S, Scheltens, P, Cummings, JL (eds.), Alzheimer's Disease and Related Disorders Annual 5. London: Taylor & Francis, 2006: 181–90.Google Scholar
Emre, M, Aarsland, D, Albanese, A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004; 351: 2509–18.CrossRefGoogle ScholarPubMed
Ferman, TJ, Smith, GE, Boeve, BF, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004; 62: 181–7.CrossRefGoogle ScholarPubMed
Fleisher, AS, Olichney, JM.Neurodegenerative disorders with diffuse cortical Lewy bodies. Adv Neurol 2005; 96: 148–65.Google ScholarPubMed
Foltynie, T, Brayne, CEG, Robbins, TW, Barker, RA.The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127: 550–60.CrossRefGoogle ScholarPubMed
Galvin, JE, Pollack, J, Morris, JC.Clinical phenotype of Parkinson disease dementia. Neurology 2006; 67: 1605–11.CrossRefGoogle ScholarPubMed
Gardner-Thorpe, C.James Parkinson 1755–1824. Exeter: Wheaton, 1987.Google Scholar
Gibb, WR, Esiri, MM, Lees, AJ.Clinical and pathological features of diffuse Lewy body disease (Lewy body dementia). Brain 1987; 110: 1131–53.CrossRefGoogle Scholar
Gnanalingham, KK, Byrne, EJ, Thornton, A.Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 1996; 347: 696–7.CrossRefGoogle ScholarPubMed
Goldman, WP, Baty, JD, Buckles, VD, Sahrmann, S, Morris, JC.Cognitive and motor functioning in Parkinson disease. Arch Neurol 1998; 55: 674–80.CrossRefGoogle ScholarPubMed
Grace, J, Daniel, S, Stevens, T, et al. Long-term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatrics 2001; 13: 199–205.CrossRefGoogle Scholar
Graham, JM, Sagar, HJ.A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord 1999; 14: 10–20.3.0.CO;2-4>CrossRefGoogle Scholar
Hamilton, JM, Salmon, DP, Galasko, D, et al. A comparison of episodic memory deficits in neuropathologically-confirmed dementia with Lewy bodies and Alzheimer's disease. J Int Neuropsychol Soc 2004; 10: 689–97.CrossRefGoogle ScholarPubMed
Hansen, L, Salmon, D, Galasko, D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40: 1–8.CrossRefGoogle ScholarPubMed
Hoehn, MM, Yahr, MD.Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427–42.CrossRefGoogle Scholar
Horimoto, Y, Matsumoto, M, Akatsu, H, et al. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol 2003; 250: 530–3.CrossRefGoogle ScholarPubMed
Ince, PG, Perry, EK, Morris, CM.Dementia with Lewy bodies: a distinct non-Alzheimer dementia syndrome?Brain Pathol 1998; 8: 299–324.CrossRefGoogle ScholarPubMed
Ishikawa, A, Piao, YS, Miyashita, A, et al. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease. Ann Neurol, 2005; 57: 429–34.CrossRefGoogle ScholarPubMed
Ivory, SJ, Knight, RG, Longmore, BE, Caradoc-Davies, T.Verbal memory in non-demented patients with idiopathic Parkinson's disease. Neuropsychologia 1999; 37: 817–28.CrossRefGoogle ScholarPubMed
Kaufmann, H, Nahm, K, Purohit, D, Wolfe, D.Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 2004; 63: 1093–5.CrossRefGoogle ScholarPubMed
Koide, T, Ohtake, H, Nakajima, T, et al. A patient with dementia with Lewy bodies and codon 232 mutation of PRNP. Neurology 2002; 59: 1619–21.CrossRefGoogle ScholarPubMed
Kraemer, C, Lang, K, Weckesser, M, Evers, S.Creutzfeldt–Jacob [sic] disease misdiagnosed as dementia with Lewy bodies. J Neurol 2005; 252: 861–2.CrossRefGoogle ScholarPubMed
Lambon Ralph, MA, Powell, J, Howard, D, et al. Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review. J Neurol Neurosurg Psychiatry 2001; 70: 149–56.CrossRefGoogle ScholarPubMed
Lange, KW, Robbins, TW, Marsden, CD, et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacol (Berl) 1992; 107: 394–404.CrossRefGoogle ScholarPubMed
Larner, AJ.Medical hazards of the internet: gambling in Parkinson's disease. Mov Disord 2006; 21: 1789.CrossRefGoogle ScholarPubMed
Larner, AJ, Mathias, CJ, Rossor, MN.Autonomic failure preceding dementia with Lewy bodies. J Neurol 2000; 247: 229–31.CrossRefGoogle ScholarPubMed
Lees, AJ, Smith, E.Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257–70.CrossRefGoogle ScholarPubMed
Leiguarda, RC, Pramstaller, PP, Merello, M, et al. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain 1997; 120: 75–90.CrossRefGoogle ScholarPubMed
Leroi, I, Brandt, J, Reich, SG, et al. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry 2004; 19: 1–8.CrossRefGoogle ScholarPubMed
Leverenz, JB, Fishel, MA, Peskind, ER, et al. Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 2006; 63: 370–6.CrossRefGoogle ScholarPubMed
Levin, BE, Llabre, MM, Reisman, S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991; 41: 365–9.CrossRefGoogle ScholarPubMed
Lewis, FM, Lapointe, L, Murdoch, BE, Chenery, HJ.Language impairment in Parkinson's disease. Aphasiology 1998; 12: 193–206.CrossRefGoogle Scholar
Lobotesis, K, Fenwick, JD, Phipps, A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56: 643–9.CrossRefGoogle Scholar
McKeith, IG, Ballard, CG, Perry, RH, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000a; 54: 1050–8.CrossRefGoogle Scholar
McKeith, I, Del Ser, T, Spano, P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000b; 356: 2031–6.CrossRefGoogle Scholar
McKeith, IG, Dickson, DW, Lowe, J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863–72.CrossRefGoogle ScholarPubMed
McKeith, I, Fairbairn, A, Perry, R, Thompson, P, Perry, E.Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305: 673–8.CrossRefGoogle ScholarPubMed
McKeith, IG, Galasko, D, Kosaka, K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113–24.CrossRefGoogle Scholar
McKeith, IG, Perry, EK, Perry, RH, for the Consortium on Dementia with Lewy Bodies. Report of the second dementia with Lewy body international workshop. Neurology 1999; 53: 902–5.CrossRefGoogle ScholarPubMed
Mortimer, JA, Pirozzola, FJ, Hansch, EC, Webster, DD.Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology 1982; 32: 133–7.CrossRefGoogle Scholar
National Collaborating Centre for Chronic Conditions. Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London: Royal College of Physicians, 2006: 121–4.
O'Brien, J, McKeith, I, Ames, D, Chiu, E (eds.). Dementia with Lewy Bodies and Parkinson's Disease Dementia. London: Taylor & Francis, 2006.Google Scholar
Owen, AM, Iddon, JL, Hodges, JR, Summers, BA, Robbins, TW.Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia 1997; 35: 519–32.CrossRefGoogle ScholarPubMed
Pillon, B, Deweer, B, Agid, Y, Dubois, B.Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol 1993; 50: 374–9.CrossRefGoogle ScholarPubMed
Portin, R, Laatu, S, Revonsuo, A, Rinne, UK.Impairment of semantic knowledge in Parkinson disease. Arch Neurol 2000; 57: 1338–43.CrossRefGoogle ScholarPubMed
Rafal, RD, Posner, MJ, Walker, JA, Friedrich, FJ.Cognition and the basal ganglia: separating mental and motor components of performance in Parkinson's disease. Brain 1984; 107: 1083–94.CrossRefGoogle ScholarPubMed
Saghal, A, Galloway, PH, McKeith, IG, et al. A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dementia 1992; 3: 350–4.Google Scholar
Salmon, DP, Galasko, D, Hansen, , et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996; 31: 148–65.CrossRefGoogle ScholarPubMed
Simard, M, Reekum, R, Myran, D.Visuospatial impairment in dementia with Lewy bodies and Alzheimer's disease: a process analysis approach. Int J Geriatr Psychiatry 2003; 18: 387–91.CrossRefGoogle ScholarPubMed
Singleton, AB, Farrer, M, Johnson, J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.CrossRefGoogle ScholarPubMed
Smith, MC, Goldman, WP, Janer, KW, Baty, JD, Morris, JC.Cognitive speed in nondemented Parkinson's disease. J Int Neuropsychol Soc 1998; 4: 584–92.CrossRefGoogle ScholarPubMed
Starkstein, SE, Merello, M.Psychiatric and Cognitive Disorders in Parkinson's Disease. Cambridge: Cambridge University Press, 2002: 55–87, 100–103.CrossRefGoogle Scholar
Stocchi, F, Brusa, L.Cognition and emotion in different stages and subtypes of Parkinson's disease. J Neurol 2000; 247 (suppl 2): II/114–21.Google ScholarPubMed
Troyer, AK, Moscovitch, M, Winocur, G, Leach, L, Freedman, M.Clustering and switching on verbal fluency tests in Alzheimer's and Parkinson's disease. J Int Neuropsychol Soc 1998; 4: 137–43.CrossRefGoogle ScholarPubMed
Walker, MP, Ayre, GA, Cummings, JL, et al. The clinical assessment of fluctuation and the one day fluctuation assessment scale: two methods to assess fluctuating confusion in dementia. Br J Psychiatry 2000; 177: 252–6.CrossRefGoogle ScholarPubMed
Zadikoff, C, Lang, AE.Apraxia in movement disorders. Brain 2005; 128: 1480–97.CrossRefGoogle ScholarPubMed
Zarranz, JJ, Alegre, J, Gomez-Esteban, JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004; 55: 164–73.CrossRefGoogle ScholarPubMed
Bak, TH, Crawford, LM, Hearn, VC, Mathuranath, PS, Hodges, JR.Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005; 11: 268–73.CrossRefGoogle Scholar
Quinn N. Other atypical parkinsonian disorders and their differentiation from dementia with Lewy bodies. In: O'Brien, J, McKeith, I, Ames, D, Chiu, E (eds.), Dementia with Lewy Bodies and Parkinson's Disease Dementia. London: Taylor & Francis, 2006a: 241–53.Google Scholar
Quinn, NP.Atypical parkinsonian syndromes. Eur J Neurol 2006b; 13 (suppl2): 3 (abstract MT 4–1).Google Scholar
Albert, ML, Feldman, RG, Willis, AL.The ‘subcortical dementia’ of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37: 121–30.CrossRefGoogle ScholarPubMed
Bak, TH, Crawford, LM, Hearn, VC, Mathuranath, PS, Hodges, JR.Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005; 11: 268–73.CrossRefGoogle Scholar
Bak, TH, Hodges, JR.The neuropsychology of progressive supranuclear palsy. Neurocase 1998; 4: 89–98.CrossRefGoogle Scholar
Brown, RG, Pillon, B, Uttner, I, Payan, C, Lacomblez, L, Members of the Neuropsychology Working Group and NNIPPS Consortium. Cognitive function in patients with progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Mov Disord 2002; 17 (suppl 5): S221 (abstract P706).Google Scholar
Davis, PH, Bergeron, C, McLachlan, DR.Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985; 17: 337–43.CrossRefGoogle ScholarPubMed
Larner, AJ.Did Charles Dickens describe progressive supranuclear palsy in 1857?Mov Disord 2002; 17: 832–3.CrossRefGoogle Scholar
Leiguarda, RC, Pramstaller, PP, Merello, M, et al. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain 1997; 120: 75–90.CrossRefGoogle ScholarPubMed
Litvan, I, Agid, Y, Calne, D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996; 47: 1–9.CrossRefGoogle Scholar
Masliah, E, Hansen, , Quijada, S, et al. Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?Ann Neurol 1991; 29: 389–96.CrossRefGoogle ScholarPubMed
Paviour, DC, Lees, AJ, Josephs, KA, et al. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 2004; 127: 2441–51.CrossRefGoogle ScholarPubMed
Pillon, B, Deweer, B, Michon, A, et al. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's and Huntington's diseases. Neurology 1994; 44: 1264–70.CrossRefGoogle ScholarPubMed
Rehman, HU.Progressive supranuclear palsy. Postgrad Med J 2000; 76: 333–6.CrossRefGoogle ScholarPubMed
Richardson, JC, Steele, J, Olszewski, J.Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia: a clinical report on eight cases of heterogeneous system degeneration. Trans Am Neurol Assoc 1963; 88: 25–9.Google Scholar
Robbins, TW, James, M, Lange, KW, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994; 57: 79–88.CrossRefGoogle ScholarPubMed
Rosser, AE, Hodges, JR.Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1994a; 57: 1389–94.CrossRefGoogle Scholar
Rosser, AE, Hodges, JR.The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy. J Neurol 1994b; 241: 531–6.CrossRefGoogle Scholar
Steele, JC, Richardson, JC, Olszewski, J.Progressive supranuclear palsy: a heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333–58.CrossRefGoogle ScholarPubMed
Williams, DR, Silva, R, Paviour, DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128: 1247–58.CrossRefGoogle ScholarPubMed
Bak, TH, Crawford, LM, Hearn, VC, Mathuranath, PS, Hodges, JR.Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005a; 11: 268–73.CrossRefGoogle Scholar
Bak, TH, Rogers, TT, Crawford, LM, et al. Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2005b; 76: 420–2.CrossRefGoogle Scholar
Boeve, BF, Lang, AE, Litvan, I.Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54 (suppl 5): S15–19.CrossRefGoogle ScholarPubMed
Boeve, BF, Maraganore, MD, Parisi, JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795–800.CrossRefGoogle ScholarPubMed
Boeve, B, Parisi, J, Petersen, R, et al. Familial dementia/parkinsonism/motor neuron disease with corticobasal degeneration pathology but absence of a tau mutation. Neurobiol Aging 2002; 23 (1S): S269 (abstract 1008).Google Scholar
Dickson, DW, Bergeron, C, Chin, SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935–46.CrossRefGoogle ScholarPubMed
Doran, M, du Plessis, DG, Enevoldson, TP, et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci 2003; 216: 127–34.CrossRefGoogle ScholarPubMed
Graham, NL, Bak, TH, Hodges, JR.Corticobasal degeneration as a cognitive disorder. Mov Disord 2003a; 18: 1224–32.CrossRefGoogle Scholar
Graham, NL, Bak, T, Patterson, K, Hodges, JR.Language function and dysfunction in corticobasal degeneration. Neurology 2003b; 61: 493–9.CrossRefGoogle Scholar
Grimes, DA, Bergeron, CB, Lang, AE.Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999a; 14: 674–80.3.0.CO;2-X>CrossRefGoogle Scholar
Grimes, DA, Lang, AE, Bergeron, CB.Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999b; 53: 1969–74.CrossRefGoogle Scholar
Kertesz A, Martinez-Lange P. Cognitive changes in corticobasal degeneration. In: Kertesz, A, Munoz, DG (eds.), Pick's Disease and Pick Complex. New York: Wiley-Liss, 1998: 121–8.Google ScholarPubMed
Kertesz A, Munoz DG. Clinical and pathological overlap in Pick complex. In: Kertesz, A, Munoz, DG (eds.), Pick's Disease and Pick Complex. New York: Wiley-Liss, 1998: 281–6.Google ScholarPubMed
Lang AE, Riley DE, Bergeron C. Cortical-basal ganglionic degeneration. In: Calne, DB (ed.), Neurodegenerative Diseases. Philadelphia: Saunders, 1994: 877–94.Google Scholar
Larner, AJ, Doran, M.Language function and dysfunction in corticobasal degeneration. Neurology 2004; 62: 1238.CrossRefGoogle ScholarPubMed
Lennox, G, Jackson, M, Lowe, J.Corticobasal degeneration manifesting as a frontal lobe dementia. Ann Neurol 1994; 36: 273–4 (abstract P52).Google Scholar
Lippa, CF, Cohen, R, Smith, TW, Drachman, DA.Primary progressive aphasia with focal neuronal achromasia. Neurology 1991; 41: 882–6.CrossRefGoogle ScholarPubMed
Mahapatra, RK, Edwards, MJ, Schott, JM, Bhatia, KP.Corticobasal degeneration. Lancet Neurol 2004; 3: 736–43.CrossRefGoogle ScholarPubMed
Massman, PJ, Kreiter, KT, Jankovic, J, Doody, RS.Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology 1996; 46: 720–6.CrossRefGoogle ScholarPubMed
Mathuranath, PS, Xuereb, JH, Bak, T, Hodges, JR.Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry 2000; 68: 304–12.CrossRefGoogle ScholarPubMed
Pillon, B, Blin, J, Vidailhet, M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995; 45: 1477–83.CrossRefGoogle ScholarPubMed
Rebeiz, JJ, Kolodny, EH, Richardson, EP.Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc 1967; 92: 23–6.Google ScholarPubMed
Tang-Wai, DF, Josephs, KA, Boeve, BF, et al. Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology 2003; 61: 1134–5.CrossRefGoogle ScholarPubMed
Thompson PD, Marsden CD. Corticobasal degeneration. In: Rossor, MN (ed.), Unusual Dementias. London: Bailliere Tindall, 1992: 677–86.Google ScholarPubMed
Zadikoff, C, Lang, AE.Apraxia in movement disorders. Brain 2005; 128: 1480–97.CrossRefGoogle ScholarPubMed
Bak, TH, Crawford, LM, Hearn, VC, Mathuranath, PS, Hodges, JR.Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005a; 11: 268–73.CrossRefGoogle Scholar
Bak, TH, Rogers, TT, Crawford, LM, et al. Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2005b; 76: 420–2.CrossRefGoogle Scholar
Brown, RG, Pillon, B, Uttner, I, Payan, C, Lacomblez, L, Members of the Neuropsychology Working Group and NNIPPS Consortium. Cognitive function in patients with progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Mov Disord 2002; 17 (suppl 5): S221 (abstract P706).Google Scholar
Geser F, Colosimo C, Wenning GK. Multiple system atrophy. In: Beal, MF, Lang, AE, Ludolph, A (eds.), Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. Cambridge: Cambridge University Press, 2005: 623–62.CrossRefGoogle Scholar
Gilman, S, Low, PA, Quinn, N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999; 163: 94–8.CrossRefGoogle Scholar
Graham, JG, Oppenheimer, DR.Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969; 32: 28–34.CrossRefGoogle Scholar
Leiguarda, RC, Pramstaller, PP, Merello, M, et al. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain 1997; 120: 75–90.CrossRefGoogle ScholarPubMed
Meco, G, Gasparini, M, Doricchi, F.Attentional functions in multiple system atrophy and Parkinson's disease. J Neurol Neurosurg Psychiatry 1996; 60: 393–8.CrossRefGoogle ScholarPubMed
Pillon, B, Gouider-Khouja, N, Deweer, B, et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995; 58: 174–9.CrossRefGoogle ScholarPubMed
Robbins, TW, James, M, Lange, KW, et al. Cognitive performance in multiple system atrophy. Brain 1992; 115: 271–91.CrossRefGoogle ScholarPubMed
Robbins, TW, James, M, Lange, KW, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994; 57: 79–88.CrossRefGoogle ScholarPubMed
Sullivan, EV, Paz, R, Zipursky, RB, Pfefferbaum, A.Neuropsychological deficits accompanying striatonigral degeneration. J Clin Exp Neuropsychol 1991; 13: 773–88.CrossRefGoogle ScholarPubMed
Corsellis, JAN, Bruton, CJ, Freeman-Browne, D.The aftermath of boxing. Psychol Med 1973; 3: 270–303.CrossRefGoogle ScholarPubMed
Echemendia, RJ, Julian, LJ.Mild traumatic brain injury in sports: neuropsychology's contribution to a developing field. Neuropsychol Rev 2001; 11: 69–88.CrossRefGoogle ScholarPubMed
Erlanger, DM, Kutner, KC, Barth, JT, Barnes, R.Neuropsychology of sports-related head injury: dementia pugilistica to post concussion syndrome. Clin Neuropsychol 1999; 13: 193–209.CrossRefGoogle ScholarPubMed
Kapur, N.Memory Disorders in Clinical Practice. Hove: Lawrence Erlbaum, 1994: 97–113.Google Scholar
Nicoll, JAR, Roberts, GW, Graham, DI.Apolipoprotein E epsilon-4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med 1995; 1: 135–7.CrossRefGoogle ScholarPubMed
Roberts, GW, Gentleman, SM, Lynch, A, et al. β-amyloid protein deposition in the brain following severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994; 57: 419–25.CrossRefGoogle Scholar
Galasko, D, Salmon, DP, Craig, UK, et al. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997–2000. Neurology 2002; 58: 90–7.CrossRefGoogle ScholarPubMed
Perl DP. Amyotrophic lateral sclerosis/parkinsonism–dementia complex of Guam. In: Strong, MJ (ed.), Dementia and Motor Neuron Disease. Abingdon: Informa Healthcare, 2006: 177–91.CrossRefGoogle Scholar
Perl, DP, Hof, PR, Steele, JC, et al. Neuropathologic studies of a pure dementing syndrome (Marianas dementia) among the inhabitants of Guam, a form of ALS/parkinsonism dementia complex. Brain Pathol 1994; 4: 529 (abstract P31-13).Google Scholar
Collinge, J.Variant Creutzfeldt–Jakob disease. Lancet 1999; 354: 317–23.CrossRefGoogle ScholarPubMed
Collinge, J.Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24: 519–50.CrossRefGoogle ScholarPubMed
Collinge, J, Owen, F, Poulter, M, et al. Prion dementia without characteristic pathology. Lancet 1990; 336: 7–9.CrossRefGoogle ScholarPubMed
Collinge, J, Palmer, MS (eds.). Prion diseases. Oxford: Oxford University Press, 1997.Google ScholarPubMed
Hegde, RS, Tremblay, P, Groth, D, et al. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 1999; 402: 822–6.CrossRefGoogle Scholar
Ironside JW, Head MW. Human prion diseases. In: Esiri, MM, Lee, VM-Y, Trojanowski, JQ (eds.), The Neuropathology of Dementia (2nd edition). Cambridge: Cambridge University Press, 2004: 402–26.CrossRefGoogle Scholar
Kovacs, GG, Trabattoni, G, Hainfellner, JA, et al. Mutations of the prion protein gene: phenotypic spectrum. J Neurol 2002; 249: 1567–82.Google ScholarPubMed
Larner, AJ, Doran, M.Prion diseases: update on therapeutic patents, 1999–2002. Exp Opin Ther Patents 2003; 13: 67–78.CrossRefGoogle Scholar
Larner, AJ, Doran, M.Prion disease at a regional neuroscience centre: retrospective audit. J Neurol Neurosurg Psychiatry 2004; 75: 1789–90.CrossRefGoogle Scholar
Palmer, MS, Dryden, AJ, Hughes, JT, Collinge, J.Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease. Nature 1991; 352: 340–2.CrossRefGoogle ScholarPubMed
Parchi, P, Giese, A, Capellari, S, et al. Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224–33.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Peden, AH, Head, MW, Ritchie, DL, Bell, JE, Ironside, JW.Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527–9.CrossRefGoogle Scholar
Prusiner, SB.Novel proteinaceous particles cause scrapie. Science 1982; 216: 136–44.CrossRefGoogle ScholarPubMed
Prusiner, SB (ed.). Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1999.Google Scholar
Prusiner, SB.Shattuck lecture: neurodegenerative diseases and prions. N Engl J Med 2001; 344: 1516–26.CrossRefGoogle Scholar
Trevitt, CR, Collinge, J.A systematic review of prion therapeutics in experimental models. Brain 2006; 129: 2241–65.CrossRefGoogle ScholarPubMed
Bergmann, M, Gullotta, F, Weitbrecht, WU.Progressive subkortikale Gliose. Fortschr Neurol Psychiat 1991; 59: 328–34.CrossRefGoogle Scholar
Cohen, D, Kutluay, E, Edwards, J, Peltier, A, Beydoun, A.Sporadic Creutzfeldt–Jakob disease presenting with nonconvulsive status epilepticus. Epilepsy Behav 2004; 5: 792–6.CrossRefGoogle ScholarPubMed
Doran, M, Larner, AJ.EEG findings in dementia with Lewy bodies causing diagnostic confusion with sporadic Creutzfeldt–Jakob disease. Eur J Neurol 2004; 11: 838–41.CrossRefGoogle ScholarPubMed
Drlicek, M, Grisold, W, Liszka, U, Hitzenberger, P, Machacek, E.Angiotropic lymphoma (malignant angioendotheliomatosis) presenting with rapidly progressive dementia. Acta Neuropathol (Berl) 1991; 82: 533–5.CrossRefGoogle ScholarPubMed
Kraemer, C, Lang, K, Weckesser, M, Evers, S.Creutzfeldt–Jacob [sic] disease misdiagnosed as dementia with Lewy bodies. J Neurol 2005; 252: 861–2.CrossRefGoogle ScholarPubMed
Mandell, AM, Alexander, MP, Carpenter, S.Creutzfeldt–Jakob disease presenting as isolated aphasia. Neurology 1989; 39: 55–8.CrossRefGoogle ScholarPubMed
Monaghan, TS, Murphy, DT, Tubridy, N, Hutchinson, M.The woman who mistook the past for the present. Adv Clin Neurosci Rehabil 2006; 6 (3); 27–8.Google Scholar
Pachalska, M, Kurzbauer, H, MacQueen, BD, Forminska-Kapuscik, M, Herman-Sucharska, I.Neuropsychological features of rapidly progressive dementia in a patient with an atypical presentation of Creutzfeldt–Jakob disease. Med Sci Monit 2001; 7: 1307–15.Google Scholar
Pellisé, A, Navarro, O, Rey, M, Cardozo, A, Ferrer, I.Protein 14-3-3 in pellagra encephalopathy. Neurologia 2002; 17: 655–6.Google ScholarPubMed
Pietrini, V.Creutzfeldt–Jakob disease presenting as Wernicke–Korsakoff syndrome. J Neurol Sci 1992; 108: 149–53.CrossRefGoogle ScholarPubMed
Reinwald, S, Westner, IM, Niedermaier, N.Rapidly progressive Alzheimer's disease mimicking Creutzfeldt–Jakob disease. J Neurol 2004; 251: 1020–2.CrossRefGoogle ScholarPubMed
Schott, JM, Warren, JD, Rossor, MN.The uncertain nosology of Hashimoto encephalopathy. Arch Neurol 2003; 60: 1812.CrossRefGoogle ScholarPubMed
Seitelberger, F.Präsenile gliale Dystrophie. Acta Neuropathol (Berl) 1968; Suppl 4: 109–18.Google Scholar
Slee, M, Pretorius, P, Ansorge, O, Stacey, R, Butterworth, R.Parkinsonism and dementia due to gliomatosis cerebri mimicking sporadic Creutzfeldt–Jakob disease (CJD). J Neurol Neurosurg Psychiatry 2006; 77: 283–4.CrossRefGoogle Scholar
Snowden, JA, Mann, DMA, Neary, D.Distinct neuropsychological characteristics in Creutzfeldt–Jakob disease. J Neurol Neurosurg Psychiatry 2002; 73: 686–94.CrossRefGoogle ScholarPubMed
Steinhoff, B, Zerr, I, Glatting, M, et al. Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease. Ann Neurol 2004; 56: 702–8.CrossRefGoogle ScholarPubMed
Tschampa, HJ, Neumann, M, Zerr, I, et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt–Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71: 33–9.CrossRefGoogle ScholarPubMed
Vaz, J, Sierazdan, K, Kane, N.Non convulsive status epilepticus in Creutzfeldt–Jakob disease: a short report. J Neurol Neurosurg Psychiatry 2005; 76: 1318 (abstract 030).Google Scholar
Zarei, M, Nouraei, SA, Caine, D, Hodges, JR, Carpenter, RH.Neuropsychological and quantitative oculometric study of a case of sporadic Creutzfeldt–Jakob disease at predementia stage. J Neurol Neurosurg Psychiatry 2002; 73: 56–8.CrossRefGoogle ScholarPubMed
Zerr, I, Pocchiari, M, Collins, S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology 2000; 55: 811–5.CrossRefGoogle Scholar
Collinge, J.Variant Creutzfeldt–Jakob disease. Lancet 1999; 354: 317–23.CrossRefGoogle ScholarPubMed
Collinge, J, Whitfield, J, McKintosh, E, et al. Kuru in the 21st century: an acquired human prion disease with very long incubation periods. Lancet 2006; 367: 2068–74.CrossRefGoogle ScholarPubMed
Cordery, RJ, Alner, K, Cipolotti, L, et al. The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease. J Neurol Neurosurg Psychiatry 2005; 76: 330–6.CrossRefGoogle ScholarPubMed
Cordery, RJ, Hall, M, Cipolotti, L, et al. Early cognitive decline in Creutzfeldt–Jakob disease associated with human growth hormone treatment. J Neurol Neurosurg Psychiatry 2003; 74: 1412–16.CrossRefGoogle ScholarPubMed
Gajdusek, DC.Unconventional viruses and the origin and disappearance of kuru. Science 1977; 197: 943–60.CrossRefGoogle ScholarPubMed
Hill, AF, Butterworth, RJ, Joiner, S, et al. Investigation of variant Creutzfeldt–Jakob disease and other human prion disease with tonsil biopsy samples. Lancet 1999; 353: 183–9.CrossRefGoogle ScholarPubMed
Hilton, DA, Fathers, E, Edwards, P, Ironside, JW, Zajicek, J.Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt–Jakob disease. Lancet 1998; 352: 703–4.CrossRefGoogle ScholarPubMed
Hilton, D, Ghani, AC, Conyers, L, et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 2002; 325: 633–4.CrossRefGoogle ScholarPubMed
Kapur, N, Abbott, P, Lowman, A, Will, RG.The neuropsychological profile associated with variant Creutzfeldt–Jakob disease. Brain 2003; 126: 2693–702.CrossRefGoogle ScholarPubMed
Kapur, N, Ironside, J, Abbott, P, et al. A neuropsychological–neuropathological case study of variant Creutzfeldt–Jakob disease. Neurocase 2001; 7: 261–7.CrossRefGoogle ScholarPubMed
Monaghan, TS, Murphy, DT, Tubridy, N, Hutchinson, M.The woman who mistook the past for the present. Adv Clin Neurosci Rehabil 2006; 6 (3); 27–8.Google Scholar
Silverdale, M, Leach, JP, Chadwick, DW.New variant Creutzfeldt–Jakob disease presenting as localization-related epilepsy. Neurology 2000; 54: 2188.CrossRefGoogle ScholarPubMed
Spencer, MS, Knight, RSG, Will, RG.First hundred cases of variant Creutzfeldt–Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 2002; 324: 1479–82.CrossRefGoogle ScholarPubMed
Wroe, SJ, Pal, S, Siddique, D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt–Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368: 2061–7.CrossRefGoogle ScholarPubMed
Zeidler, M, Sellar, RJ, Collie, DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt–Jakob disease. Lancet 2000; 355: 1412–8.CrossRefGoogle ScholarPubMed
Zigas, V.Laughing death: the untold story of kuru. Clifton NJ: Humana, 1990.CrossRefGoogle Scholar
Cordery, RJ, Alner, K, Cipolotti, L, et al. The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease. J Neurol Neurosurg Psychiatry 2005; 76: 330–6.CrossRefGoogle ScholarPubMed
Farlow, MR, Yee, RD, Dlouhy, SR, et al. Gerstmann–Straussler–Scheinker disease. I. Extending the clinical spectrum. Neurology 1989; 39: 1446–52.CrossRefGoogle ScholarPubMed
Gallassi, R, Morreale, A, Montagna, P, Gambetti, P, Lugaresi, E.Fatal familial insomnia: neuropsychological study of a disease with thalamic degeneration. Cortex 1992; 28: 175–87.CrossRefGoogle ScholarPubMed
Gallassi, R, Morreale, A, Montagna, P, et al. Fatal familial insomnia: behavioral and cognitive features. Neurology 1996; 46: 935–9.CrossRefGoogle ScholarPubMed
Gass, CS, Luis, CA, Meyers, TL, Kuljis, RO.Familial Creutzfeldt–Jakob disease: a neuropsychological case study. Arch Clin Neuropsychol 2000; 15: 165–75.Google ScholarPubMed
Kovacs, GG, Trabattoni, G, Hainfellner, JA, et al. Mutations of the prion protein gene: phenotypic spectrum. J Neurol 2002; 249: 1567–82.Google ScholarPubMed
Nitrini, R, Rosemberg, S, Passos-Bueno, MR, et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 1997; 42: 138–46.CrossRefGoogle ScholarPubMed
Nitrini, R, Teixeira-da-Silva, LS, Rosemberg, S, et al. Prion disease resembling frontotemporal dementia and parkinsonism linked to chromosome 17. Arq Neuropsiquiatr 2001; 59: 161–4.CrossRefGoogle ScholarPubMed
Scaravilli, F, Cordery, RJ, Kretschmar, H, et al. Sporadic fatal insomnia: a case study. Ann Neurol 2000; 48: 665–8.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Unverzagt, FW, Farlow, MR, Norton, J, et al. Neuropsychological function in patients with Gerstmann–Straussler disease from the Indiana kindred (F198S). J Int Neuropsychol Soc 1997; 3: 169–78.Google Scholar
Albert MS. Normal and abnormal memory: aging and Alzheimer's disease. In: Wang, E, Snyder, DS (eds.), Handbook of the Aging Brain. San Diego: Academic Press, 1998: 1–17.Google Scholar
Arnold, SE, Hyman, BT, Flory, J, Damasio, AR, Hoesen, GW.The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1991; 1: 103–16.CrossRefGoogle ScholarPubMed
Braak, H, Braak, E.Neuropathological stageing [sic] of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239–59.CrossRefGoogle ScholarPubMed
DeKosky ST, Ikonomovic MD, Hamilton RL, Bennett DA, Mufson EJ. Neuropathology of mild cognitive impairment in the elderly. In: Gauthier, S, Scheltens, P, Cummings, JL (eds.), Alzheimer's Disease and Related Disorders Annual 5. London: Taylor & Francis, 2006: 1–16.Google Scholar
leon, MJ, Desanti, S, Zinkowski, R, et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med 2004; 256: 205–23.CrossRefGoogle ScholarPubMed
Gauthier, S, Touchon, J.Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005; 62: 1164–6.CrossRefGoogle Scholar
Gilman, S, Koller, M, Black, RS, et al. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005; 64: 1553–62.CrossRefGoogle Scholar
Golomb, J, Kluger, A, Garrard, P, Ferris, S.Clinician's Manual on Mild Cognitive Impairment. London: Science Press, 2001.Google Scholar
Gómez-Isla T, Hyman BT. Neuropathological changes in normal aging, mild cognitive impairment, and Alzheimer's disease. In: Petersen, RC (ed.), Mild Cognitive Impairment: Aging to Alzheimer's Disease. Oxford: Oxford University Press, 2003: 191–204.Google Scholar
Hughes, CP, Berg, L, Danziger, WL, Coben, , Martin, RL.A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566–72.CrossRefGoogle Scholar
Jack, CR, Petersen, RC, Xu, YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397–403.CrossRefGoogle ScholarPubMed
Karas, GB, Scheltens, P, Rombouts, SARB, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004; 23: 708–16.CrossRefGoogle ScholarPubMed
Kordower, JH, Chu, Y, Stebbins, GT, et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001; 49: 202–13.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
Korf, ESC, Wahlund, LO, Visser, PJ, Scheltens, P.Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: 94–100.CrossRefGoogle ScholarPubMed
Larner, AJ.‘Posterior cortical atrophy’ or ‘focal-onset Alzheimer's disease’? A clinical, neuropsychological and neuroimaging study. J Neurol 2004a; 251 (suppl 3): III102 (abstract P385).Google Scholar
Larner, AJ.Getting it wrong: the clinical misdiagnosis of Alzheimer's disease. Int J Clin Pract 2004b; 58: 1092–4.CrossRefGoogle Scholar
Larner, AJ.Secretases as therapeutic targets in Alzheimer's disease: patents 2000–2004. Exp Opin Therap Patents 2004c; 14: 1403–20.CrossRefGoogle Scholar
Levine, DN, Lee, JM, Fisher, CM.The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 1993; 43: 305–13.CrossRefGoogle ScholarPubMed
McKhann, G, Drachman, D, Folstein, M, et al. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer's disease. Neurology 1984; 34: 939–44.CrossRefGoogle Scholar
Markesbery, WR, Schmitt, FA, Kryscio, RJ, et al. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006; 63: 38–46.CrossRefGoogle ScholarPubMed
Morris, J.The CDR: current version and scoring rules. Neurology 1993; 43: 2412–4.CrossRefGoogle ScholarPubMed
Morris, JC.Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Arch Neurol 2006; 63: 15–16.CrossRefGoogle ScholarPubMed
Perneczky, R, Pohl, C, Sorg, C, et al. Impairment of activities of daily living requiring memory of complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry 2006; 21: 158–62.CrossRefGoogle ScholarPubMed
Petersen, RC (ed.). Mild Cognitive Impairment: Aging to Alzheimer's Disease. Oxford: Oxford University Press, 2003.Google Scholar
Petersen, RC.Mild cognitive impairment: current research and clinical implications. Semin Neurol 2007; 27: 22–31.CrossRefGoogle ScholarPubMed
Petersen, RC, Morris, JC.Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005; 62: 1160–3.CrossRefGoogle ScholarPubMed
Petersen, RC, Smith, GE, Waring, SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–8.CrossRefGoogle ScholarPubMed
Petersen, RC, Thomas, RG, Grundman, M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379–88.CrossRefGoogle ScholarPubMed
Portet, F, Ousset, PJ, Visser, PJ, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry 2006; 77: 714–18.CrossRefGoogle Scholar
Reisberg, B, Ferris, SH, Leon, MJ, Crook, T.The Global Deterioration Scale (GDS) for assessment of primary degenerative dementia. Am J Psych 1982; 139: 1136–9.Google Scholar
Ritchie, K, Touchon, J.Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000; 355: 225–8.CrossRefGoogle ScholarPubMed
Salloway, S, Ferris, S, Kluger, A, et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004; 63: 651–7.CrossRefGoogle ScholarPubMed
Schenk, D, Barbour, R, Dunn, W, et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173–7.CrossRefGoogle ScholarPubMed
Tuokko, HA, Hultsch, DF (eds.). Mild Cognitive Impairment: International Perspectives. London: Taylor & Francis, 2006.Google Scholar
Visser, PJ, Verhey, FRJ, Scheltens, P, et al. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects. J Neurol 2002; 249: 312–19.CrossRefGoogle Scholar
Winblad, B, Palmer, K, Kivipelto, M, et al. Mild cognitive impairment: beyond controversies, towards a consensus. Report of the International Working Group on Mild Cognitive Impairment. J Int Med 2004; 256: 240–6.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×